Conference abstract
NLRP3 inflammasome plays an important role in the innate immune response to Acinetobacter Baumannii infection
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The opportunistic Gram-negative bacterium Acinetobacter Baumannii (AB) is a leading cause of life-threatening nosocomial pneumonia. Outbreaks of multidrug resistant (MDR)-AB belonging to International Clones (ICs) I and II with limited treatment options are major global health threats. However, the pathogenesis mechanisms of various AB clonal groups are understudied. Although inflammation-associated interleukin-1β (IL-1β) levels and IL-1 receptor antagonist polymorphisms were previously implicated in MDR-AB-related pneumonia in patients, whether inflammasomes has any role in the host defense and/or pathogenesis of clinically relevant Acinetobacter Baumannii infection is unknown. Using a sub-lethal mouse pneumonia model, we demonstrate that an extensively drug-resistant clinical isolate (ICII) of Acinetobacter Baumannii exhibits reduced/delayed early pulmonary neutrophil recruitment, higher lung persistence and most importantly, elicits enhanced IL-1β/IL-18 production and lung damage through NLRP3 inflammasome, in comparison with Acinetobacter Baumannii type strain. Acinetobacter Baumannii infection-induced IL-1β/IL-18 production is entirely dependent on NLRP3ASC-caspase-1/caspase-11 pathway. Using Nlrp3-/- mice infection models, we further show that while NLRP3 inflammasome pathway contributes to host defense against Acinetobacter Baumannii clinical isolate, it is dispensable for protection against Acinetobacter Baumannii type strain. Our study reveals a novel differential role for NLRP3 inflammasome pathway in the immunity against clinically relevant Acinetobacter Baumannii infections and highlights inflammasome pathway as a potential immune-modulatory target.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Neha Dikshit”
- BylineArticles whose byline prints “Bindu Sukumaran”
